CNBC CanSino Biologics CEO on earnings, business outlook, and international partnerships Posted: April 30, 2025 | Last updated: April 30, 2025 Yu Xuefeng, CEO of Chinese vaccine company CanSino ...

Credit: Sundry Photography / Shutterstock. Merck & Co (MSD) has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in Delaware, US. The 470,000ft² facility is set ...

Through digital, live and print products, Cosmetics Business informs and inspires business leaders and decision-makers around the world. With a digital-first strategy, the Group’s Editors write ...

Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "At WuXi Biologics, we believe that long-term business success is inseparable from our responsibility to people, ...

manufacturing and warehouse capabilities to enable the launch and commercial production of next-generation biologics and therapies including potent antibody-drug conjugates (ADCs), reinforcing ...

The board of Vimta Labs at its meeting held on 28 April 2025 has approved the company's foray into Biologics Contract Research and Development with an investment of Rs 50 crore. The foray into this ...

Haier Smart Home and WuXi Biologics all rose 0.22 percent, CNOOC improved 0.83 percent, CSPC Pharmaceutical surrendered 1.15 percent, Galaxy Entertainment retreated 1.06 percent, Hang Lung ...

Contributing to United Nations Sustainable Development Goals Enhancing transparency and effectiveness for corporate governance Empowering employees and delivering positive impact to communities ...